e.g. mhealth
Search Results (1 to 10 of 19 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 6 JMIR Research Protocols
- 5 JMIR Formative Research
- 4 Journal of Medical Internet Research
- 2 JMIR Diabetes
- 1 JMIR Human Factors
- 1 Online Journal of Public Health Informatics
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 JMIR XR and Spatial Computing (JMXR)
Type 2 diabetes mellitus (T2 DM) has become a global public health issue that significantly affects 90% of the 537 million patients with T2 DM worldwide [1]. T2 DM and its complications significantly impact patients and the society by increasing health care costs and reducing life expectancy and quality [2]. Glycated hemoglobin (Hb A1c) is the gold standard for measuring average blood glucose levels over 3 months and predicting the relative risk of diabetes complications [3,4].
JMIR Form Res 2025;9:e72659
Download Citation: END BibTex RIS
It has been proposed that improving health literacy in T2 DM management requires innovative solutions, including the use of simplified and interactive educational tools [12,13]. This study evaluated an artificial intelligence (AI)–driven conversational agent chatbot to enhance health literacy on T2 DM by providing interactive, accessible, and personalized guidance grounded in evidence-based medical documents.
J Med Internet Res 2025;27:e70131
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Type 2 diabetes mellitus (T2 DM) has become a serious public health problem worldwide. It is a progressive disease that can impair health-related quality of life [1,2] while also imposing substantial economic burdens on individuals, health systems, and society [3]. By 2040, there will be 642 million patients with diabetes worldwide, with the incidence of T2 DM on the rise across all regions [4]. T2 DM accounts for >90% of the diagnosis in all types of diabetes, and it can cause various complications [5].
J Med Internet Res 2025;27:e63209
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
In recent years, the number of patients with type 2 diabetes mellitus (T2 DM) has been on the rise due to unhealthy diets, sedentary lifestyles, and an aging population [1]. The epidemic is only expected to worsen, with the number of adults with diabetes predicted to reach 415 million by 2040, costing the health care system US $802 billion a year [2]. Improving diabetes treatment is essential.
J Med Internet Res 2024;26:e53740
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section